Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Lomas

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
Pharmacoeconomics|April 16, 2020
Conducting Value for Money Analyses for Non-randomised Interventional Studies Including Service Evaluations: An Educational Review with RecommendationsMatthew Franklin, James Lomas, Gerry Richardson
BMJ Open|October 11, 2020
Is an ounce of prevention worth a pound of cure? A cross-sectional study of the impact of English public health grant on mortality and morbidityStephen Martin, James Lomas, Karl Claxton
Health Economics|April 3, 2018
The impact of NHS expenditure on health outcomes in England: Alternative approaches to identification in all-cause and disease specific models of mortalityKarl Claxton, James Lomas, Stephen Martin
Health Policy and Planning|August 19, 2021
Accounting for country- and time-specific values in the economic evaluation of health-related projects relevant to low- and middle-income countriesJames Lomas, Karl Claxton, Jessica Ochalek
Health Economics|May 2, 2015
Healthcare Cost Regressions: Going Beyond the Mean to Estimate the Full DistributionAndrew M Jones, James Lomas, Nigel Rice
Annals of Internal Medicine|November 2, 2020
A Health Opportunity Cost Threshold for Cost-Effectiveness Analysis in the United StatesDavid J Vanness, James Lomas, Hannah Ahn
Health Economics|July 28, 2021
Does public long-term care expenditure improve care-related quality of life of service users in England?Francesco Longo, Karl Claxton, James Lomas, et al.
Health Policy (Amsterdam, Netherlands)|April 2, 2023
The impact of different types of NHS expenditure on health: Marginal cost per QALY estimates for England for 2016/17Stephen Martin, Karl Claxton, James Lomas, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 24, 2018
Resolving the "Cost-Effective but Unaffordable" Paradox: Estimating the Health Opportunity Costs of Nonmarginal Budget ImpactsJames Lomas, Karl Claxton, Stephen Martin, et al.
Applied Health Economics and Health Policy|March 14, 2022
How Responsive is Mortality to Locally Administered Healthcare Expenditure? Estimates for England for 2014/15Stephen Martin, Karl Claxton, James Lomas, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
Pharmacoeconomics|April 16, 2020
Conducting Value for Money Analyses for Non-randomised Interventional Studies Including Service Evaluations: An Educational Review with RecommendationsMatthew Franklin, James Lomas, Gerry Richardson
BMJ Open|October 11, 2020
Is an ounce of prevention worth a pound of cure? A cross-sectional study of the impact of English public health grant on mortality and morbidityStephen Martin, James Lomas, Karl Claxton
Health Economics|April 3, 2018
The impact of NHS expenditure on health outcomes in England: Alternative approaches to identification in all-cause and disease specific models of mortalityKarl Claxton, James Lomas, Stephen Martin
Health Policy and Planning|August 19, 2021
Accounting for country- and time-specific values in the economic evaluation of health-related projects relevant to low- and middle-income countriesJames Lomas, Karl Claxton, Jessica Ochalek
Health Economics|May 2, 2015
Healthcare Cost Regressions: Going Beyond the Mean to Estimate the Full DistributionAndrew M Jones, James Lomas, Nigel Rice
Annals of Internal Medicine|November 2, 2020
A Health Opportunity Cost Threshold for Cost-Effectiveness Analysis in the United StatesDavid J Vanness, James Lomas, Hannah Ahn
Health Economics|July 28, 2021
Does public long-term care expenditure improve care-related quality of life of service users in England?Francesco Longo, Karl Claxton, James Lomas, et al.
Health Policy (Amsterdam, Netherlands)|April 2, 2023
The impact of different types of NHS expenditure on health: Marginal cost per QALY estimates for England for 2016/17Stephen Martin, Karl Claxton, James Lomas, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 24, 2018
Resolving the "Cost-Effective but Unaffordable" Paradox: Estimating the Health Opportunity Costs of Nonmarginal Budget ImpactsJames Lomas, Karl Claxton, Stephen Martin, et al.
Applied Health Economics and Health Policy|March 14, 2022
How Responsive is Mortality to Locally Administered Healthcare Expenditure? Estimates for England for 2014/15Stephen Martin, Karl Claxton, James Lomas, et al.
Pageof 6